Indivumed Services company information, Employees & Contact Information

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation Yahoo Finance

Crown Bioscience and NEXT Oncology Cement Partnership Extension Via TT

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities FinancialContent

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration Nature

Crown Bioscience Strategically Strengthens Leadership Team and Names New Chief Financial Officer PR Newswire

Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project Nasdaq

Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina Via Ritzau

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership Business Wire

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development FinancialContent

CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings Business Wire

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services FinancialContent

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024 FinancialContent

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank Business Wire

Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer Business Wire

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership Business Wire

Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels FinancialContent

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery News-Medical

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project GlobeNewswire

Crown Bioscience Announces Transaction Closing of Indivumed's Service Business and Supporting Biobank FinancialContent

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership FinancialContent

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research News-Medical

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc. News-Medical

Crown Bioscience Acquires OcellO Contract Pharma

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE PR Newswire

Is Boston losing its biotech crown? BIO conference takes place amidst industry fears MassLive

Using radiation models to improve cancer therapies: an interview with Adrian Treverton, COO of Xstrahl and Jean-Pierre Wery, President of Crown Bioscience News-Medical

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening Via TT

JSR buys up CRO Crown Biosciences in $400M deal Fierce Biotech

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies Via TT

NIRC lands pharmaceutical facility theind.com